Companies: 10,795·Total market cap: $144.5T
Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

ETONNASDAQHealthcare● Active
$28.81
$-0.32(-1.10%)
Market Cap$789173834
P/E Ratio
52W High$35.66
52W Low$13.09
Overview

Eton Pharmaceuticals, Inc. (ETON) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ETON · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.05eton eps ttm · eton earnings per shareEarnings history
PE Ratio (TTM)eton pe ratio ttm · eton price to earningsPE Ratio deep dive
Revenue (TTM)$86.9Meton revenue ttm · eton annual revenueFull revenue history
Dividend YieldNo Dividenddoes eton pay dividends · eton dividend yieldDividend history
Shares Outstanding26.9Meton shares outstanding · eton floatShares outstanding history
Next EarningsAug 6, 2026Est.eton earnings date · eton next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$80.0M▲ +104.94% YoY
202320242025
eton pharmaceuticals, inc. revenue · eton revenue 2025
FY 2025Net Income-$4.6M▼ 20.35% YoY
202320242025
eton pharmaceuticals, inc. net income · eton profit 2025
FY 2025EPS$-0.17▼ 13.33% YoY
202320242025
eton eps · eton pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $86.9MNet Income: -$1.5MEPS: $-0.05View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis eton a buy · eton analyst rating
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$57.00Low
$28.81Current
$57.00Avg Target97.85% upside
$57.00High
eton price target · eton 12 month forecast

Total: 6 · Buy rate: 100.0%

The ETON analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $57.00, representing +97.85% upside from the current price of $28.81.

Stock Performance

Full History
1D-0.72%
1W+6.32%
1M-2.46%
3M+72.14%
YTD+71.02%
1Y+82.46%
5Y+358.32%

About Eton Pharmaceuticals, Inc.

CEOSean E. Brynjelsen
IPO DateNov 13, 2018
Employees31
CountryUS

Eton Pharmaceuticals, Inc. a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine inject…

what is eton pharmaceuticals, inc. · eton stock overview · eton pharmaceuticals, inc. company profile · who is eton pharmaceuticals, inc. ceo · eton NASDAQ · eton pharmaceuticals, inc. headquarters · eton pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Eton Pharmaceuticals, Inc. (ETON) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 13, 2018. As of the latest trading session, ETON stock price is $28.81, with a market capitalization of $789.2M. The stock has returned +82.46% over the past 12 months and +71.02% year-to-date.

According to 6 Wall Street analysts, the consensus rating for Eton Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $57.00. In fiscal year 2025, Eton Pharmaceuticals, Inc. reported revenue of $80.0M and net income of -$4.6M. For detailed data — including Eton Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Eton Pharmaceuticals, Inc. (ETON) stock price is $28.81. The stock is traded on NASDAQ under the ticker symbol ETON. The 52-week range is $13.09 – $35.66.

ETON stock priceETON quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice